Profil
Qi Zhu is currently Director-Medical Affair at Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. and Chief Medical Officer at Cutia Therapeutics since 2019.
Formerly, Mr. Zhu was Director-Medical Affair at AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. from 2013 to 2015.
Education includes an MBA from Shanghai University of Finance & Economics in 2005, a graduate degree from Shanghai University in 2001, and an undergraduate degree from Shanghai University in 1995.
Aktive Positionen von Qi Zhu
| Unternehmen | Position | Beginn |
|---|---|---|
| CUTIA THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 09.09.2019 |
Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd.
Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. Electronic ComponentsElectronic Technology Manufactures optical lenses | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Qi Zhu
| Unternehmen | Position | Ende |
|---|---|---|
AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01.09.2015 |
Ausbildung von Qi Zhu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Shanghai University of Finance & Economics
Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd.
Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd. Electronic ComponentsElectronic Technology Manufactures optical lenses | Electronic Technology |
AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | |
Cutia Therapeutics
Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
















